Skip to content

Newsroom

type
year
Illustration image.png

EU’s Urban Wastewater Treatment Directive could lead to additional costs of nearly EUR 1 billion in Finland alone, posing a serious threat to medicine availability

2/13/2025 Press release
Illustration image.png

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

2/12/2025 Flagging notifications
Illustration image.png

Save the Date: Orion’s Capital Markets Day on 22 May 2025

2/10/2025 Press release
orionfi_global_orion_japan_paakuva_1500x844.jpg

Entrepreneurial spirit and a fast-growing team – This is how Orion Pharma Japan took off

2/4/2025 We are Orion
Illustration image.png

Orion and Invenra announce discovery service and commercial license agreement to develop innovative bispecific antibody cancer therapeutics

1/30/2025 Press release
Illustration image.png

Orion publishes Financial Statement Release for 2024 and holds a webcast on 25 February 2025

1/28/2025 Press release
Illustration image.png

Inside information: Orion upgrades full-year outlook for 2024 and provides preliminary information on financial performance for 2024

1/15/2025 Stock exchange release
Illustration image.png

Recommendation by the Orion Nomination Committee on the proposals to be submitted to the 2025 Annual General Meeting

1/15/2025 Stock exchange release
Illustration image.png

79,345 Orion Corporation A shares converted into B shares

1/13/2025 Stock exchange release
Illustration image.png

Orion’s collaboration partner Bayer submits application in China for third indication of darolutamide

1/7/2025 Press release
Illustration image.png

Orion and Marinus terminate agreement for ganaxolone in Europe

12/30/2024 Press release
Illustration image.png

CORRECTION: Change in Orion Group Executive Management Board as of 1 June 2025 – Mikko Kemppainen appointed General Counsel

12/19/2024 Stock exchange release
Illustration image.png

Change in Orion Group Executive Management Board as of 1 June 2025 – Mikko Kemppainen appointed General Counsel

12/19/2024 Stock exchange release
Illustration image.png

Orion and Abilita Therapeutics announce research collaboration and option to license agreement to develop innovative antibody therapeutics

12/18/2024 Press release
orionfi_nuoretkohderyhmana_paakuva1_1500x844.jpg

Pathways to the pharmaceutical industry – This is how Orion encourages young people to find their place

12/13/2024 We are Orion
Illustration image.png

Penalty payment to a member of Orion’s Board of Directors for delay in notifying managers’ transaction

12/12/2024 Stock exchange release
orion_huoltovarmuus_paakuva_1500x844.jpg

Orion’s Nordic pharmaceutical production means security for all of Europe

12/2/2024 Orion and Society
orion_ajatusjohtaja_parkinsons_paakuva_1500x844.jpg

More than just tremors – What we should understand about Parkinson’s disease

11/27/2024 Your Health